Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar timing with cisplatin + docetaxel in first-line advanced NSCLC
ChiCTR-TRC-12001891Phase 4Completed
- Sponsor
- Nantong Cancer Hospital
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of endostar in non-small cell lung cancer (NSCLC) (3 arms), sponsored by Nantong Cancer Hospital. Primary endpoints: Progression-free survival, 1-year survival rate and 5 more. Started Jan 2011; status: completed.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-TRC-12001891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12001891.